Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization "ICAR"


Phase N/A Results N/A

Summary of Purpose

The combination of aspirin and dipyridamole, two antiplatelet drugs, is approved in Italy for the secondary prevention of cerebral embolism in patients with carotid atherosclerosis. Besides antiplatelet activity, Dipyridamole has additional pharmacological action, including vasodilation and antioxidant properties. A role for oxidative stress has been suggested in acute cerebrovascular disease. In this ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 December 2015.

1 Sep 2010 26 May 2015 1 Jun 2014 1 Dec 2014 1 Dec 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Investigator)
  • Endpoint: Bio-equivalence Study
  • Intervention: Parallel Assignment


Not available